Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), bought 8,308 shares at $1.17 ($10K) on 2024-04-08, disclosed to the SEC on 2024-04-10.
Open-market purchase of $10k BRTX by VP of Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.13 | 476 | $538 | 5.3% |
| 2 | $1.17 | 1,232 | $1K | 14.1% |
| 3 | $1.25 | 6,600 | $8K | 80.7% |
| Total | $1.23 avg | 8,308 | $10K | 100% |
| Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $2K | — | Filing → |